Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083889
Status:
COMPLETED
Last Update Posted:
2010-01-26
First Post:
2004-06-03
Brief Title:
SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
Sponsor:
Organization:
Pfizer